A recent study conducted by Brkić et al. [66] revealed that overexpression of SMAD2, a canonical second messenger activated by activin A through ALK4 signalling, significantly suppressed the ability of trophoblasts to form endothelial-like networks conveying a potential link between elevated activin A levels and preeclampsia pathogenesis. Here, SMAD2 is linked to preeclampsia.